Plain-English translation of NCT07077876 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is studying a fertility-preserving approach for women with early-stage uterine cancer or precancerous uterine conditions. Instead of removing the uterus, doctors use a minimally invasive camera procedure called hysteroscopy to remove the abnormal tissue, then insert a levonorgestrel-releasing intrauterine device (IUD) and sometimes prescribe oral progestin medication to help prevent the condition from returning. The study will track pregnancy outcomes and cancer recurrence over time.
Standard treatment for uterine cancer typically involves removing the entire uterus, which ends any chance of pregnancy. This trial exists to learn whether a gentler, uterus-preserving approach works well for younger women or those who want to have children, and to understand how safe and effective this treatment is in the long term.
You likely qualify if…
You likely don't qualify if…
You will have already received the minimally invasive hysteroscopic procedure to remove abnormal tissue, plus an IUD insertion, possibly along with oral progestin pills. After that, you'll return for follow-up visits with tissue biopsies at 3 months, 6 months, and 12 months to monitor whether the condition is responding to treatment. The researchers will track whether you become pregnant and monitor for any signs of cancer recurrence over time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Italy